Cash Pay Is Transforming the Pharmacy. Medical Care Is Next.

Not long ago, paying for a prescription was a guessing game. You handed over your card at the counter, hoped your copay was reasonable, and had no idea whether the same pill cost less down the street. Then, in the last 3-5 years, a quiet revolution happened: cash-pay pharmacy went mainstream. GoodRx put real discount prices in everyone's pocket. Mark Cuban's Cost Plus Drugs, launched in 2022, published a transparent cash price for hundreds of medications. Amazon Pharmacy made prices visible before you checked out. Suddenly, millions of people discovered they could often pay less in cash than they would through their own insurance. The "default" has shifted from "why would you pay cash" to "why would you use a PBM"?

This isn't a finished story — but the path is now clear, and it's working. It also points directly at what comes next. The same problem cash pay is solving at the pharmacy — hidden prices, wild variation, surprise costs — still defines almost every medical service outside the pharmacy. Wellward exists to fix that side of the equation, using the same idea that's already transforming how people pay for prescriptions.

How mainstream cash pay has actually become

It's easy to underestimate how fast this shift has happened. A few signs of how normal paying cash for medications now is:

About 38% of Americans said they used a prescription discount card or coupon in 2025 — nearly four in ten people. And roughly 70% of GoodRx's users have insurance, which means most people reaching for a cash discount aren't uninsured at all. They simply found that the cash price beat what their plan would charge, and took it. Paying cash is no longer a fallback for the uninsured; it's a mainstream way smart, insured consumers save money.

It has lowered prices — and improved access

The most important part isn't the convenience. It's that transparent cash pricing has measurably expanded access to medications people need.

GLP-1s are the clearest example. As cash-pay channels opened up, the price of popular weight-loss and diabetes drugs fell dramatically. Through direct-to-consumer programs like LillyDirect and NovoCare, the monthly cash price of injectables like Wegovy, Ozempic, and Zepbound dropped from around $499 to the $300s. And the newest oral GLP-1 pills now start as low as $149 a month in cash — roughly 70% below where these drugs sat just a year or two earlier. Medications that were effectively out of reach for cash-paying patients suddenly weren't.

Insulin is another. After years of public pressure, major manufacturers capped out-of-pocket insulin costs at around $35 a month — a transparent, predictable price that put a life-sustaining drug back within reach for people who'd been rationing it.

Everyday generics, too. Cost Plus Drugs made headlines by selling common generic medications for a transparent markup over actual cost — sometimes a small fraction of what patients had been paying. When the price is visible and fair, people fill the prescriptions they were skipping.

In each case, the pattern is the same: make the price transparent and fair, and millions more people can actually get the medicine. That's accessibility, not just savings.

Even health plans are buying in

This isn't a fringe movement anymore — payers are building it into how plans work. Blue Shield of California, a nonprofit insurer covering nearly five million members, restructured its entire pharmacy model around transparent cash-style pricing, bringing in Mark Cuban's Cost Plus Drugs and Amazon Pharmacy and projecting around $500 million in annual savings. When a major health plan reorganizes its drug benefit around transparent pricing, the idea has officially moved from the margins to the mainstream.

The same problem still rules medical care

Now look at everything beyond the pharmacy counter: MRIs, CT scans, lab work, dental, physicals, specialist visits, outpatient procedures. This is where most healthcare spending actually happens, and it's stuck roughly where prescriptions were five years ago.

The same MRI can be $250 or $1,800 a few miles apart. A routine set of labs can swing by hundreds of dollars depending on which door you walk through. And almost none of those prices are visible before you receive care. The result is the same one the pharmacy world is escaping: people overpay because they can't see, can't compare, and can't plan — and many simply delay care they need because they're afraid of the bill.

Wellward: the cash-pay model, applied to medical services

This is the gap Wellward fills, and we frame it the same way we frame everything: making care more affordable, removing the surprises, and making the finances simpler.

More affordable. Just as GoodRx finds the lowest cash price for your prescription, we find the lowest fair price for your scan, lab, visit, or procedure. The savings are out there — they're just buried in phone trees and billing departments instead of a clean app. We dig them out for you.

Fewer surprises. Like seeing a drug's price before you fill it, we get you a real, specific price for your care before you go. No surprise at checkout, no dreaded statement weeks later. You decide with the number in hand.

Simpler finances. A cash-pay prescription is gloriously simple: one price, paid once, no claim to chase. We bring that same simplicity to medical services — a clear price for a clearly defined service, without the deductible math and coinsurance puzzles.

There's one important difference. A prescription is standardized — a 30-day supply of a specific drug is the same everywhere. A medical service isn't. An "MRI" depends on the body part, whether contrast is used, and what's included. That's why we don't just publish a static price list. Our team actually calls providers in your area, gathers current cash-pay prices for the exact service you need, benchmarks them for fairness, and weighs convenience and quality too — with a real person behind every search.

Who this helps most

Transparent cash pricing for medical care isn't just for one kind of person. It changes the math for almost everyone who pays out of pocket — which, increasingly, is almost everyone.

If you're uninsured, cash pay isn't a workaround — it's your whole path to care. Knowing the real, fair price for an MRI or a set of labs before you go is the difference between getting care and avoiding it. We make sure you never overpay simply because you don't have a plan.

If you need to go out of network, the "out-of-network" sticker price is often wildly inflated — but the cash price for the same service can be far lower. When your plan's network doesn't have the right provider, we help you find a fair cash price instead of an eye-watering out-of-network bill.

If you have a high-deductible plan, you're effectively paying full price for most care until you hit your deductible — whether you realize it or not. In that window, shopping the cash price can cost you less than running it through your own insurance, exactly the way GoodRx often beats a copay at the pharmacy.

And if you simply want to be a smart shopper, you don't need a reason. Just as millions of insured people now reach for the cash price on their prescriptions because it's cheaper, you can do the same for your scans, labs, and visits.

The next chapter of affordable healthcare

The pharmacy is showing the country what's possible: that healthcare prices can be transparent, that cash can win, that access actually improves when prices come into the light — and that even big insurers will build around it. That chapter is well underway. The much bigger one — medical care itself — is just beginning. Wellward is building it: taking the model that's already making prescriptions more affordable and applying it to the scans, labs, visits, and procedures where most of your healthcare dollars actually go.